Skip to main navigation Skip to search Skip to main content

The Lancet: Cansino phase 2 trial finds vaccine is safe and induces an immune response

  • W. Chen

Press/Media: Expert Comment

Period23 Jul 2020

Media coverage

1

Media coverage